Chunshan Wei
No. 15, Yingchun Road
Luohu, 518033, China
Luohu, 518033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Underlying mechanisms of Traditional Chinese Medicine in treating metabolic dysfunction-associated steatohepatitis: evidences from preclinical and clinical studies.
Journal: Journal of ethnopharmacology
Published: November 25, 2024
Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review.
Journal: Integrative cancer therapies
Published: October 30, 2024
A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: June 04, 2024
Integrating Network Pharmacology and In Vitro Experiments for Assessing the Anti-Tumor Effects of Phyllanthus Urinaria L Anti-neoplastic Decoction in Hepatocellular Carcinoma.
Journal: Alternative therapies in health and medicine
Published: May 17, 2024
Effect of lidocaine pumped through hepatic artery to relieve pain of hepatic artery infusion chemotherapy.
Journal: Frontiers in surgery
Published: January 29, 2024
In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Journal: Computational and mathematical methods in medicine
Published: August 24, 2022
Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model.
Journal: Frontiers in pharmacology
Published: July 09, 2022
Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease.
Journal: European journal of pediatrics
Published: March 31, 2022
Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 17, 2021
Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis.
Journal: Environmental toxicology and pharmacology
Published: December 26, 2019
Compound Phyllanthus urinaria L Inhibits HBV-Related HCC through HBx-SHH Pathway Axis Inactivation.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: October 20, 2018
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.
Journal: World journal of hepatology
Published: October 05, 2018
Last Updated: 09/26/2026